Patent Application Titled "Nature and formation mechanism of red blood cells and platelets and the mechanism of new artificial blood" Published Online (USPTO 20240309325).

Předmět:
Zdroj: Hematology Week; 10/11/2024, p894-894, 1p
Abstrakt: A patent application titled "Nature and formation mechanism of red blood cells and platelets and the mechanism of new artificial blood" has been published online. The inventors propose that nucleated red blood cells, rather than enucleated erythrocytes, are the best structure for blood oxygen transmission. They also suggest that platelets are not essential for hemostasis and coagulation and can be replaced by other cells in the blood. The inventors claim that producing artificial blood with nucleated red blood cells, without platelets, can reduce the production cycle and cost of artificial blood, meet the needs of medical blood supply shortages, and reduce the demand for blood donation. The patent application provides more detailed information on the mechanisms and preparation of this proposed artificial blood. [Extracted from the article]
Databáze: Complementary Index